This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here's WhyThe Motley Fool • 11/18/25
PTC Therapeutics, Inc. (PTCT) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/11/25
Compared to Estimates, PTC Therapeutics (PTCT) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/05/25
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial ResultsPRNewsWire • 11/04/25
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/28/25
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial ResultsPRNewsWire • 10/21/25
PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/08/25
PTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/08/25
PTC Therapeutics, Inc. (PTCT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/08/25
PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy ConcernsBenzinga • 08/19/25
PTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to SayZacks Investment Research • 08/07/25
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial ResultsPRNewsWire • 08/07/25
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/31/25